Мировой рынок сердечных клапанов – тенденции отрасли и прогноз до 2030 года

Настройте свой отчет Настройте свой отчет Купить сейчас Купить сейчас Бесплатный пример отчета Бесплатный пример отчета
Дом Healthcare Global Heart Valve Devices Market
Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Мировой рынок сердечных клапанов – тенденции отрасли и прогноз до 2030 года

  • Healthcare
  • Published Report
  • Nov 2022
  • Global
  • 350 Pages
  • Количество таблиц: 706
  • Количество рисунков: 69
Купить сейчасКупить сейчас

Global Heart Valve Devices Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Chart Image 23,665.51 2022 2030
Diagram Прогнозируемый период
 2023 –2030
Diagram Размер рынка (базовый год)
 МИЛЛИОН ДОЛЛАРОВ США
Запрос
Diagram Размер рынка (прогнозируемый год)
 USD 23,665.51
Diagram CAGR
 %
Diagram Основные игроки рынка
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Запрос на разблокировку

>Глобальный рынок устройств для протезирования сердечных клапанов по типу продукции (механические клапаны сердца, биологические клапаны сердца и транскатетерные клапаны), лечению (открытая хирургия и малоинвазивная хирургия (MIS)), конечному пользователю (больницы и клиники, амбулаторные хирургические центры , кардиологические центры, исследовательские центры и другие), каналу сбыта (прямой тендер, сторонние дистрибьюторы), тенденциям отрасли и прогнозу до 2030 года.

Рынок устройств для сердечного клапана

Download PDF Get Exclusive Sample PDF of this Report Here

Анализ рынка сердечных клапанов и аналитика

Устройства клапанов сердца используются для лечения заблокированных клапанов сердца, и имплантация этих устройств является одной из самых распространенных процедур. Структурные устройства клапанов сердца, доступные на рынке, включают механические, биологические и транскатетерные клапаны. Глобальный рынок устройств клапанов сердца, вероятно, будет неуклонно расти в течение прогнозируемого периода из-за увеличения числа операций на клапанах сердца по всему миру. Ожидается, что рост глобального рынка устройств клапанов сердца будет обусловлен разработками в области структурных устройств сердца и процедур, таких как аортальные клапаны, устройства окклюзии левого предсердия и тканевые или биологические клапаны. Тканевые клапаны уже произвели революцию на рынке устройств клапанов сердца. Операции на клапанах сердца следующего поколения, предлагающие низкие профили пациентов для доставки, более контролируемые операции, лучшую функцию клапана, сниженную параклапанную регургитацию, повышенную долговечность и более низкие затраты. Инновации в продуктах от ключевых игроков рынка ускорили рост рынка, позволив им охватить большее количество пациентов и достичь лучших клинических результатов.

Рынок устройств для сердечного клапана

Download PDF Get Exclusive Sample PDF of this Report Here

Рынок устройств для сердечного клапана

Download PDF Get Exclusive Sample PDF of this Report Here

Data Bridge Market Research анализирует, что рынок устройств для клапанов сердца, как ожидается, достигнет значения 23 665,51 млн долларов США к 2030 году, при среднегодовом темпе роста 13,4% в течение прогнозируемого периода. Тип продукта составляет самый большой сегмент типа на рынке из-за быстрого спроса на устройства для клапанов сердца во всем мире. Этот отчет о рынке также подробно охватывает анализ цен, патентный анализ и технологические достижения.

Отчет Метрика

Подробности

Прогнозируемый период

2023-2030

Базовый год

2022

Исторические годы

2021 (Можно настроить на 2020 - 2015)

Количественные единицы

Доход в млн. долл. США, объемы в единицах, цены в долл. США

Охваченные сегменты

По типу продукции (механические клапаны сердца, биологические клапаны сердца и транскатетерные клапаны), лечению (открытая хирургия и малоинвазивная хирургия (МИХ)), конечному пользователю (больницы и клиники, амбулаторные хирургические центры, кардиологические центры, исследовательские центры и другие), каналу сбыта (прямой тендер, сторонние дистрибьюторы).

Страны, охваченные

США, Канада, Мексика, Германия, Франция, Великобритания, Италия, Россия, Испания, Нидерланды, Швейцария, Норвегия, Польша, Швеция, Бельгия, Турция, Дания, Финляндия и остальные страны Европы, Китай, Япония, Индия, Австралия, Новая Зеландия, Южная Корея, Сингапур, Малайзия, Таиланд, Индонезия, Филиппины, Вьетнам, Тайвань и остальные страны Азиатско-Тихоокеанского региона, Южная Африка, Саудовская Аравия, Бахрейн, ОАЭ, Кувейт, Оман, Катар, Израиль, Египет и остальные страны Ближнего Востока и Африки, Бразилия, Аргентина и остальные страны Южной Америки.

Охваченные участники рынка

Abbott, Boston Scientific Corporation или ее филиалы, Artivion, Inc., Edwards Lifesciences Corporation, Medtronic, NeoVasc, Micro Interventional Devices Incorporated, XELTIS, TTK, Meril Life Sciences Pvt. Ltd, Foldax, Inc., Venus Medtech (Hangzhou) Inc., Colibri Heart Valve и другие.
Download PDF Get Exclusive Sample PDF of this Report Here

Определение мирового рынка устройств для протезирования сердечных клапанов

Сердечные клапаны необходимы для плавного движения крови в правильном направлении в организме. Сердечные клапаны отвечают за постоянный кровоток и поддержание артериального давления. Если они не работают должным образом, отключение сердца вызывает стеноз. Сердечные заболевания обычно включают несколько заболеваний, которые существенно влияют на сердце. Регулирование сердечных клапанов быстро возросло за последние десять лет, поскольку число пациентов, страдающих сердечно-сосудистыми заболеваниями, увеличилось. Рост рынка сердечных клапанов ускоряется такими факторами, как нестабильный образ жизни, болезни образа жизни, рост курящего населения, старение населения и повышение качества здравоохранения, а также быстрое развитие возмещения расходов на здравоохранение в течение прогнозируемого периода. Кроме того, высокая стоимость сердечных клапанов и риск инфицирования сердечных имплантатов могут быть причиной того, что, вероятно, замедлит рост рынка сердечных клапанов в течение вышеупомянутого прогнозируемого периода. Рост аспектов медицинского бизнеса и наработки в развивающихся экономиках подпитывают рост медицинского туризма, стимулируя рынок устройств для сердечных клапанов. Потребность в минимально инвазивных процедурах для лечения сердечных аномалий значительно возросла. Текущие применения автоматизации в хирургии сердечных клапанов, такие как транскатетерная замена аортального клапана (TAVR), уступили место растущему разнообразию подобных операций. Судя по растущей доле стареющего населения, ожидается, что увеличение полисов страхования жизни также будет способствовать росту рынка сердечных клапанов.

Динамика мирового рынка устройств для протезирования сердечных клапанов

В этом разделе рассматривается понимание движущих сил рынка, преимуществ, возможностей, ограничений и проблем. Все это подробно обсуждается ниже:    

Драйверы

  • Инновации в области устройств для сердечных клапанов обеспечивают улучшенные клинические результаты

Запуск новых продуктов для минимально инвазивных процедур, вероятно, будет стимулировать глобальный рынок устройств для сердечных клапанов. Тканевые клапаны произвели революцию на рынке сердечных клапанов. Следующее поколение хирургии сердечных клапанов предлагает меньше кривых доставки, более контролируемое размещение, улучшенную функцию клапана, сниженную регургитацию клапана, повышенную долговечность и сниженную стоимость. Инновации в продуктах повысили перспективы роста игроков на рынке устройств для сердечных клапанов, поскольку они могут лечить большее количество пациентов с превосходными клиническими результатами. Несмотря на значительные достижения последних лет, структурная интервенционная кардиология остается развивающимся рынком с большим потенциалом.

Более того, интеллектуальные проекты, новые технологии и приложения биоматериалов продолжают расширять границы разработки новых продуктов, гарантируя, что эти устройства будут на переднем крае инноваций в области интервенционных продуктов в течение многих лет. Инновации в дизайне помогают участникам рынка использовать возможности прибыльного роста в области устройств для сердечных клапанов.

Таким образом, ожидается, что рост мирового рынка устройств для протезирования клапанов сердца будет обусловлен ростом инноваций в этой области.

  • Растет число различных заболеваний сердца

Сердечные приступы и инсульты обычно являются острыми событиями и в первую очередь вызваны закупоркой, которая блокирует приток крови к сердцу или мозгу. В течение первого года пандемии COVID-19 смертность от сердечных заболеваний и инсультов увеличилась на 5,8% и 6,8% соответственно. Однако связанный с возрастом рост составил 1,6% и 1,7% для сердечных заболеваний и инсульта соответственно. Наиболее распространенной причиной является накопление жировых отложений в слизистой оболочке кровеносных сосудов, снабжающих сердце или мозг. Инсульт может быть вызван кровотечением или тромбами в кровеносном сосуде мозга. Эта тенденция предполагает, что заболеваемость сердечно-сосудистыми заболеваниями может резко возрасти из-за роста населения и старения.

Кроме того, высокий уровень диабета и артериального давления, высокий уровень холестерина в крови и курение являются ключевыми факторами риска сердечных заболеваний. Около половины людей в Соединенных Штатах (47%) имеют по крайней мере один из этих трех факторов риска. Другие медицинские состояния и образ жизни также могут повышать риск сердечных заболеваний, включая нездоровое питание, физическую неактивность и чрезмерное употребление алкоголя.

Более того, ожидается, что рост числа заболеваний сердца станет движущей силой развития мирового рынка сердечных клапанов.

Рынок устройств для сердечного клапана

Download PDF Get Exclusive Sample PDF of this Report Here

Возможность

  • Повышение осведомленности о протезных устройствах

Протез — это устройство, предназначенное для замены отсутствующей части тела или для улучшения функции части тела. Протезы клапанов сердца все чаще используются в случаях аномалий естественных клапанов, требующих вмешательства. Как правило, их можно разделить на механические сердечные клапаны, биологические клапаны и аллогенные трансплантаты. Цель искусственных клапанов — действовать гемодинамически как естественный клапан с минимальными побочными эффектами. Устройства сердечно-сосудистых протезов были разработаны для замены поврежденной сердечной ткани. Эти медицинские устройства предназначены для имитации функции нормальных сердечно-сосудистых органов. Искусственные сердца позволяют кардиохирургам увеличить лечение сердечных блокад.

Более того, распространенность искусственных клапанов колеблется от 0,2 на 1000 человек у людей в возрасте лет и моложе до 5,3 у людей в возрасте лет и моложе.

Таким образом, растущая осведомленность о протезных устройствах создает возможности для роста рынка.

Сдержанность/Вызов

  • Высокая себестоимость оборудования

Число пациентов, проходящих лечение по поводу аортального клапана в США, быстро растет. Транскатетерная замена аортального клапана (TAVR) заменяет хирургическую замену аортального клапана (SAVR) и медикаментозное лечение (MT). Экономические последствия этих тенденций неизвестны. Поэтому общая стоимость TAVR выше, чем SAVR, и намного дороже, чем только MT. Стоимость TAVR со временем снизилась, тогда как стоимость SAVR и MT осталась прежней.

Кроме того, высокая хирургическая стоимость TAVI в основном обусловлена ​​высокой стоимостью производства. Однако из-за более короткого пребывания в больнице стоимость нехирургической TAVI ниже по сравнению с AVR. Стоимость только набора имплантатов TAVI (клапан, баллон, оболочка) составляет 32 500 долларов США, тогда как хирургический клапан стоит всего около 5 000 долларов США, как и в Швейцарии, набор имплантатов TAVI стоит около 32 000 франков (около 35 000 долларов США), тогда как стоимость биохирургического протеза составляет около 3 000 швейцарских франков (около 3 300 долларов США). В зависимости от сопутствующих заболеваний и осложнений возмещение в США составляет от 0 000 до 5 000 долларов США, TAVI в Швейцарии — около 72 000 франков (78 000 долларов США), а AVR — около 3 000 франков (7 000 долларов США), что означает финансовые потери для больницы.

Таким образом, рост себестоимости оборудования может сдержать рост рынка.

Последние события

  • В сентябре 2023 года компания Abbott опубликовала данные пяти презентаций на поздней стадии, демонстрирующие преимущества ее минимально инвазивных устройств в лечении людей с различными структурными заболеваниями сердца. Данные включают выводы, которые подтверждают ценность MitraClip™. Это первая в мире и ведущая транскатетерная реконструкция от края до края (TEER) для лечения негерметичных клапанов у людей с митральной регургитацией (МР). Новые данные о структурных сердечных терапиях компании Abbott были представлены на 34-м ежегодном научном симпозиуме Фонда кардиоваскулярных исследований по транскатетерной кардиоваскулярной терапии (TCT) в Бостоне. Это помогло компании укрепить свои позиции на рынке.
  • В сентябре 2020 года Boston Scientific Corporation объявила о том, что она представила контролируемый запуск системы аортального клапана ACURATE neo2™ в Европе. Эта технология транскатетерной имплантации аортального клапана (TAVI) нового поколения представляет собой новую платформу, разработанную с множеством функций для улучшения клинических показателей оригинальной новой платформы ACURATE. По сравнению с предыдущим поколением система клапана ACURATE neo2 имеет расширенные показания для пациентов с аортальным стенозом. Это помогло компании расширить свой продуктовый портфель.

Масштаб мирового рынка устройств для протезирования сердечных клапанов

Рынок устройств для клапанов сердца сегментирован по типу продукта, лечению, конечному пользователю и каналу сбыта. Рост среди сегментов помогает вам анализировать нишевые карманы роста и стратегии для выхода на рынок и определять основные области применения и разницу в ваших целевых рынках.

ПО ТИПУ ПРОДУКТА

  • Механические сердечные клапаны
  • Биологические клапаны сердца
  • Транскатетерные клапаны

По типу продукции рынок сердечных клапанов сегментируется на механические сердечные клапаны, биологические сердечные клапаны и транскатетерные клапаны.

ПО ЛЕЧЕНИЮ

  • ОТКРЫТАЯ ХИРУРГИЯ
  • МИНИМАЛЬНО ИНВАЗИВНАЯ ХИРУРГИЯ

По принципу лечения рынок сердечных клапанов сегментируется на открытую хирургию и малоинвазивную хирургию.

 КОНЕЧНЫМ ПОЛЬЗОВАТЕЛЕМ

  • БОЛЬНИЦА И КЛИНИКИ
  • АМБУЛАТОРНЫЕ ХИРУРГИЧЕСКИЕ ЦЕНТРЫ
  • СЕРДЕЧНЫЕ ЦЕНТРЫ
  • ИССЛЕДОВАТЕЛЬСКИЕ ЦЕНТРЫ
  • ДРУГИЕ

В зависимости от конечного пользователя рынок устройств для протезирования сердечных клапанов сегментируется на больницы и клиники, амбулаторные хирургические центры, кардиологические центры, научно-исследовательские центры и другие.

ПО КАНАЛУ РАСПРОСТРАНЕНИЯ

  • ПРЯМОЙ ТЕНДЕР
  • СТОРОННИЕ ДИСТРИБЬЮТОРЫ

Рынок устройств для сердечного клапана

Download PDF Get Exclusive Sample PDF of this Report Here

По каналам сбыта рынок сердечных клапанов сегментируется на прямые поставки и сторонних дистрибьюторов.

Региональный анализ/информация о мировом рынке устройств для протезирования клапанов сердца

Проведен анализ рынка устройств для протезирования сердечных клапанов и предоставлена ​​информация о размере рынка, типе продукта, лечении, конечном пользователе и канале сбыта.

Страны, охваченные данным отчетом о рынке: США, Канада, Мексика, Германия, Франция, Великобритания, Италия, Россия, Испания, Нидерланды, Швейцария, Норвегия, Польша, Швеция, Бельгия, Турция, Дания, Финляндия и остальные страны Европы, Китай, Япония, Индия, Австралия, Новая Зеландия, Южная Корея, Сингапур, Малайзия, Таиланд, Индонезия, Филиппины, Вьетнам, Тайвань и остальные страны Азиатско-Тихоокеанского региона, Южная Африка, Саудовская Аравия, Бахрейн, ОАЭ, Кувейт, Оман, Катар, Израиль, Египет и остальные страны Ближнего Востока и Африки, Бразилия, Аргентина и остальные страны Южной Америки.

Северная Америка доминирует на рынке из-за растущих инвестиций в НИОКР. США доминируют в регионе Северной Америки из-за сильного присутствия ключевых игроков. Германия доминирует в регионе Европы из-за массового производства устройств для сердечных клапанов и растущего спроса со стороны развивающихся рынков и расширения отраслей здравоохранения. Китай доминирует в Азиатско-Тихоокеанском регионе из-за роста доступности устройств для хирургии заболеваний сердечных клапанов.

Рынок устройств для сердечного клапана

Download PDF Get Exclusive Sample PDF of this Report Here

Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании на внутреннем рынке, которые влияют на текущие и будущие тенденции рынка. Такие данные, как новые продажи, заменяющие продажи, демографические данные страны, нормативные акты и импортно-экспортные тарифы, являются одними из основных указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по стране учитываются наличие и доступность глобальных брендов и их проблемы из-за большой или малой конкуренции со стороны местных и внутренних брендов, а также влияние каналов продаж.

Анализ конкурентной среды и доли мирового рынка устройств для протезирования сердечных клапанов

Конкурентная среда рынка сердечных клапанов содержит сведения о конкурентах. Включены сведения о компании, финансах компании, полученном доходе, рыночном потенциале, инвестициях в НИОКР, новых рыночных инициативах, производственных площадках и объектах, сильных и слабых сторонах компании, запуске продукта, испытаниях продукта, одобрении продукта, патентах, широте и дыхании продукта, доминировании приложений, жизненно важной кривой технологий. Приведенные выше данные относятся только к фокусу компании на рынке сердечных клапанов.

Некоторые из ключевых игроков, работающих на рынке устройств для сердечных клапанов, включают Abbott, Boston Scientific Corporation или ее дочерние компании, Artivion, Inc., Edwards Lifesciences Corporation, Medtronic, NeoVasc, Micro Interventional Devices Incorporated, XELTIS, TTK, Meril Life Sciences Pvt. Ltd, Foldax, Inc., Venus Medtech (Hangzhou) Inc., Colibri Heart Valve и другие.

Методология исследования: мировой рынок сердечных клапанов

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Рыночные данные анализируются и оцениваются с использованием рыночных статистических и когерентных моделей. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в рыночном отчете. Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Помимо этого, модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, анализ доли рынка компании, стандарты измерения, глобальный против регионального и анализ доли поставщика. Пожалуйста, запросите звонок аналитика в случае дальнейшего запроса.

Доступна настройка

Data Bridge Market Research — лидер в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их цели. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам требуются данные, в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых необработанных файлах Excel, сводных таблицах (Factbook) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Содержание

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL HEART VALVE DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 SOURCE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 EPIDEMIOLOGY

3.2 PESTEL ANALYSIS

3.3 PORTER'S FIVE FORCE

4 MARKET OVERVIEW

4.1 DRIVERS

4.1.1 INNOVATIONS IN HEART VALVE DEVICES OFFER IMPROVED CLINICAL OUTCOME

4.1.2 RISING NUMBER OF VARIOUS HEART DISEASES

4.1.3 ADVANCEMENTS IN TRANSCATHETER VALVE TECHNOLOGY

4.1.4 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES

4.2 RESTRAINTS

4.2.1 HIGH COST ASSOCIATED WITH THE SURGERIES

4.2.2 COMPLICATIONS ASSOCIATED WITH HEART VALVE REPLACEMENT

4.3 OPPORTUNITIES

4.3.1 INCREASING AWARENESS OF PROSTHETIC DEVICES

4.3.2 RISING PREVALENCE OF STROKE & CARDIAC ARREST TO REINFORCE DEMAND FOR HEART VALVE DEVICES

4.3.3 INCREASING FDA APPROVALS OF TRANSCATHETER AORTIC VALVES

4.4 CHALLENGES

4.4.1 STRICT GOVERNMENT REGULATIONS

4.4.2 EXPENSIVE PRODUCTION COST OF EQUIPMENT

5 GLOBAL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE

5.1 OVERVIEW

5.2 MECHANICAL HEART VALVES

5.2.1 AORTIC VALVE

5.2.2 MITRAL VALVE

5.3 BIOLOGICAL HEART VALVES

5.3.1 AORTIC VALVE

5.3.2 MITRAL VALVE

5.3.3 PULMONARY VALVE

5.3.4 TRICUSPID VALVE

5.4 TRANSCATHETER VALVE

5.4.1 AORTIC VALVE

5.4.2 MITRAL VALVE

5.4.3 PULMONARY VALVE

6 GLOBAL HEART VALVE DEVICES MARKET, BY TREATMENT

6.1 OVERVIEW

6.2 MINIMALLY INVASIVE SURGERY (MIS)

6.2.1 CARDIAC VALVE REPLACEMENT

6.2.2 CARDIAC VALVE REPAIR

6.3 OPEN SURGERY

6.3.1 CARDIAC VALVE REPLACEMENT

6.3.2 CARDIAC VALVE REPAIR

7 GLOBAL HEART VALVE DEVICES MARKET, BY END USER

7.1 OVERVIEW

7.2 HOSPITAL & CLINICS

7.3 AMBULATORY SURGICAL CENTERS

7.4 CARDIAC CENTERS

7.5 RESEARCH CENTERS

7.6 OTHERS

8 GLOBAL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL

8.1 OVERVIEW

8.2 DIRECT TENDER

8.3 THIRD PARTY DISTRIBUTORS

9 GLOBAL HEART VALVE DEVICES MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 U.S.

9.2.2 CANADA

9.2.3 MEXICO

9.3 SOUTH AMERICA

9.3.1 BRAZIL

9.3.2 ARGENTINA

9.3.3 REST OF SOUTH AMERICA

9.4 EUROPE

9.4.1 GERMANY

9.4.2 FRANCE

9.4.3 U.K.

9.4.4 ITALY

9.4.5 RUSSIA

9.4.6 SPAIN

9.4.7 TURKEY

9.4.8 NETHERLANDS

9.4.9 SWITZERLAND

9.4.10 BELGIUM

9.4.11 DENMARK

9.4.12 SWEDEN

9.4.13 POLAND

9.4.14 NORWAY

9.4.15 FINLAND

9.4.16 REST OF EUROPE

9.5 ASIA-PACIFIC

9.5.1 CHINA

9.5.2 JAPAN

9.5.3 SOUTH KOREA

9.5.4 INDIA

9.5.5 AUSTRALIA

9.5.6 SINGAPORE

9.5.7 TAIWAN

9.5.8 THAILAND

9.5.9 MALAYSIA

9.5.10 INDONESIA

9.5.11 PHILIPPINES

9.5.12 NEW ZEALAND

9.5.13 VIETNAM

9.5.14 REST OF ASIA-PACIFIC

9.6 MIDDLE EAST AND AFRICA

9.6.1 SOUTH AFRICA

9.6.2 SAUDI ARABIA

9.6.3 U.A.E.

9.6.4 EGYPT

9.6.5 ISRAEL

9.6.6 KUWAIT

9.6.7 QATAR

9.6.8 OMAN

9.6.9 BAHRAIN

9.6.10 REST OF MIDDLE EAST AND AFRICA

10 GLOBAL HEART VALVE DEVICES MARKET: COMPANY LANDSCAPE

10.1 COMPANY SHARE ANALYSIS: GLOBAL

10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

10.3 COMPANY SHARE ANALYSIS: EUROPE

10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

11 SWOT ANALYSIS

12 COMPANY PROFILE

12.1 MEDTRONIC

12.1.1 COMPANY SNAPSHOT

12.1.2 REVENUE ANALYSIS

12.1.3 COMPANY SHARE ANALYSIS

12.1.4 PRODUCT PORTFOLIO

12.1.5 RECENT DEVELOPMENTS

12.2 EDWARDS LIFESCIENCES CORPORATION

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUE ANALYSIS

12.2.3 COMPANY SHARE ANALYSIS

12.2.4 PRODUCT PORTFOLIO

12.2.5 RECENT DEVELOPMENTS

12.3 ABBOTT

12.3.1 COMPANY SNAPSHOT

12.3.2 REVENUE ANALYSIS

12.3.3 COMPANY SHARE ANALYSIS

12.3.4 PRODUCT PORTFOLIO

12.3.5 RECENT DEVELOPMENTS

12.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.

12.4.1 COMPANY SNAPSHOT

12.4.2 REVENUE ANALYSIS

12.4.3 COMPANY SHARE ANALYSIS

12.4.4 PRODUCT PORTFOLIO

12.4.5 RECENT DEVELOPMENT

12.5 ARTIVION, INC.

12.5.1 COMPANY SNAPSHOT

12.5.2 REVENUE ANALYSIS

12.5.3 COMPANY SHARE ANALYSIS

12.5.4 PRODUCT PORTFOLIO

12.5.5 RECENT DEVELOPMENTS

12.6 COLIBRI HEART VALVE

12.6.1 COMPANY SNAPSHOT

12.6.2 PRODUCT PORTFOLIO

12.6.3 RECENT DEVELOPMENTS

12.7 FOLDAX, INC.

12.7.1 COMPANY SNAPSHOT

12.7.2 PRODUCT PORTFOLIO

12.7.3 RECENT DEVELOPMENTS

12.8 MERIL LIFE SCIENCES PVT. LTD.

12.8.1 COMPANY SNAPSHOT

12.8.2 PRODUCT PORTFOLIO

12.8.3 RECENT DEVELOPMENTS

12.9 MICRO INTERVENTIONAL DEVICES, INCORPORATED.

12.9.1 COMPANY SNAPSHOT

12.9.2 PRODUCT PORTFOLIO

12.9.3 RECENT DEVELOPMENTS

12.1 NEOVASC

12.10.1 COMPANY SNAPSHOT

12.10.2 REVENUE ANALYSIS

12.10.3 PRODUCT PORTFOLIO

12.10.4 RECENT DEVELOPMENTS

12.11 TTK

12.11.1 COMPANY SNAPSHOT

12.11.2 REVENUE ANALYSIS

12.11.3 PRODUCT PORTFOLIO

12.11.4 RECENT DEVELOPMENTS

12.12 VENUS MEDTECH (HANGZHOU) INC.

12.12.1 COMPANY SNAPSHOT

12.12.2 REVENUE ANALYSIS

12.12.3 PRODUCT PORTFOLIO

12.12.4 RECENT DEVELOPMENTS

12.13 XELTIS

12.13.1 COMPANY SNAPSHOT

12.13.2 PRODUCT PORTFOLIO

12.13.3 RECENT DEVELOPMENTS

13 QUESTIONNAIRE

14 RELATED REPORTS

Список таблиц

TABLE 1 GLOBAL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 2 GLOBAL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 GLOBAL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 4 GLOBAL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 5 GLOBAL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 6 GLOBAL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 7 GLOBAL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 GLOBAL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 9 GLOBAL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 10 GLOBAL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 11 GLOBAL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 12 GLOBAL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 13 GLOBAL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 14 GLOBAL HOSPITALS & CLINICS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 15 GLOBAL AMBULATORY SURGICAL CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 16 GLOBAL CARDIAC CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 GLOBAL RESEARCH CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 18 GLOBAL OTHERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 19 GLOBAL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 20 GLOBAL DIRECT TENDER IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 GLOBAL THIRD PARTY DISTRIBUTORS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 GLOBAL HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 24 NORTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 26 NORTH AMERICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 33 U.S. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 34 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 35 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 36 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 37 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 38 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 39 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 40 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 41 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 42 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 43 U.S. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 44 U.S. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 45 U.S. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 46 U.S. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 47 U.S. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 48 CANADA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 49 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 50 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 51 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 52 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 53 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 54 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 55 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 56 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 57 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 58 CANADA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 59 CANADA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 60 CANADA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 61 CANADA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 62 CANADA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 63 MEXICO HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 64 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 65 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 66 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 67 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 68 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 69 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 70 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 71 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 72 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 73 MEXICO HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 74 MEXICO MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 75 MEXICO OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 76 MEXICO HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 77 MEXICO HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 78 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 79 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 80 SOUTH AMERICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 81 SOUTH AMERICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 82 SOUTH AMERICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 83 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 84 SOUTH AMERICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 85 SOUTH AMERICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 86 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 87 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 88 BRAZIL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 89 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 90 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 91 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 92 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 93 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 94 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 95 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 96 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 97 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 98 BRAZIL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 99 BRAZIL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 100 BRAZIL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 101 BRAZIL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 102 BRAZIL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 103 ARGENTINA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 104 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 105 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 106 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 107 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 108 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 109 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 110 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 111 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 112 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 113 ARGENTINA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 114 ARGENTINA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 115 ARGENTINA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 116 ARGENTINA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 117 ARGENTINA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 118 REST OF SOUTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 119 EUROPE HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 120 EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 121 EUROPE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 122 EUROPE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 123 EUROPE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 124 EUROPE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 125 EUROPE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 126 EUROPE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 127 EUROPE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 128 EUROPE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 129 GERMANY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 130 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 131 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 132 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 133 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 134 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 135 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 136 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 137 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 138 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 139 GERMANY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 140 GERMANY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 141 GERMANY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 142 GERMANY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 143 GERMANY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 144 FRANCE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 145 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 146 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 147 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 148 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 150 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 151 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 152 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 153 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 154 FRANCE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 155 FRANCE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 156 FRANCE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 157 FRANCE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 158 FRANCE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 159 U.K. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 160 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 161 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 162 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 163 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 164 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 165 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 166 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 167 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 168 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 169 U.K. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 170 U.K. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 171 U.K. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 172 U.K. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 173 U.K. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 174 ITALY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 175 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 176 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 177 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 178 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 179 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 180 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 181 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 182 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 183 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 184 ITALY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 185 ITALY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 186 ITALY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 187 ITALY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 188 ITALY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 189 RUSSIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 191 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 192 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 193 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 194 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 195 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 196 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 197 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 198 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 199 RUSSIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 200 RUSSIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 201 RUSSIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 202 RUSSIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 203 RUSSIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 204 SPAIN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 205 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 206 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 207 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 208 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 209 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 210 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 211 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 212 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 213 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 214 SPAIN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 215 SPAIN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 216 SPAIN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 217 SPAIN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 218 SPAIN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 219 TURKEY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 220 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 221 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 222 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 223 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 224 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 225 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 226 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 227 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 228 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 229 TURKEY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 230 TURKEY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 231 TURKEY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 232 TURKEY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 233 TURKEY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 234 NETHERLANDS HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 235 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 236 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 237 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 238 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 239 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 240 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 241 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 242 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 243 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 244 NETHERLANDS HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 245 NETHERLANDS MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 246 NETHERLANDS OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 247 NETHERLANDS HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 248 NETHERLANDS HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 249 SWITZERLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 250 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 251 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 252 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 253 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 254 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 255 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 256 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 257 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 258 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 259 SWITZERLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 260 SWITZERLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 261 SWITZERLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 262 SWITZERLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 263 SWITZERLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 264 BELGIUM HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 265 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 266 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 267 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 268 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 269 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 270 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 271 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 272 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 273 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 274 BELGIUM HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 275 BELGIUM MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 276 BELGIUM OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 277 BELGIUM HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 278 BELGIUM HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 279 DENMARK HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 280 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 281 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 282 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 283 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 284 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 285 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 286 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 287 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 288 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 289 DENMARK HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 290 DENMARK MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 291 DENMARK OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 292 DENMARK HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 293 DENMARK HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 294 SWEDEN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 295 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 296 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 297 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 298 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 299 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 300 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 301 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 302 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 303 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 304 SWEDEN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 305 SWEDEN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 306 SWEDEN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 307 SWEDEN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 308 SWEDEN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 309 POLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 310 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 311 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 312 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 313 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 314 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 315 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 316 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 317 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 318 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 319 POLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 320 POLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 321 POLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 322 POLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 323 POLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 324 NORWAY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 325 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 326 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 327 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 328 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 329 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 330 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 331 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 332 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 333 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 334 NORWAY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 335 NORWAY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 336 NORWAY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 337 NORWAY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 338 NORWAY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 339 FINLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 340 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 341 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 342 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 343 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 344 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 345 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 346 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 347 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 348 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 349 FINLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 350 FINLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 351 FINLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 352 FINLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 353 FINLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 354 REST OF EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 355 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 356 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 357 ASIA-PACIFIC MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 358 ASIA-PACIFIC BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 359 ASIA-PACIFIC TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 360 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 361 ASIA-PACIFIC MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 362 ASIA-PACIFIC OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 363 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 364 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 365 CHINA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 366 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 367 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 368 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 369 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 370 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 371 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 372 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 373 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 374 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 375 CHINA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 376 CHINA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 377 CHINA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 378 CHINA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 379 CHINA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 380 JAPAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 381 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 382 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 383 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 384 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 385 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 386 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 387 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 388 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 389 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 390 JAPAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 391 JAPAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 392 JAPAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 393 JAPAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 394 JAPAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 395 SOUTH KOREA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 396 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 397 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 398 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 399 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 400 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 401 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 402 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 403 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 404 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 405 SOUTH KOREA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 406 SOUTH KOREA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 407 SOUTH KOREA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 408 SOUTH KOREA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 409 SOUTH KOREA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 410 INDIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 411 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 412 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 413 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 414 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 415 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 416 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 417 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 418 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 419 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 420 INDIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 421 INDIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 422 INDIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 423 INDIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 424 INDIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 425 AUSTRALIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 426 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 427 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 428 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 429 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 430 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 431 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 432 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 433 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 434 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 435 AUSTRALIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 436 AUSTRALIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 437 AUSTRALIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 438 AUSTRALIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 439 AUSTRALIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 440 SINGAPORE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 441 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 442 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 443 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 444 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 445 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 446 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 447 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 448 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 449 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 450 SINGAPORE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 451 SINGAPORE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 452 SINGAPORE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 453 SINGAPORE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 454 SINGAPORE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 455 TAIWAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 456 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 457 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 458 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 459 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 460 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 461 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 462 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 463 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 464 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 465 TAIWAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 466 TAIWAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 467 TAIWAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 468 TAIWAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 469 TAIWAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 470 THAILAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 471 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 472 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 473 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 474 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 475 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 476 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 477 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 478 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 479 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 480 THAILAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 481 THAILAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 482 THAILAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 483 THAILAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 484 THAILAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 485 MALAYSIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 486 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 487 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 488 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 489 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 490 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 491 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 492 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 493 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 494 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 495 MALAYSIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 496 MALAYSIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 497 MALAYSIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 498 MALAYSIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 499 MALAYSIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 500 INDONESIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 501 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 502 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 503 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 504 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 505 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 506 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 507 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 508 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 509 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 510 INDONESIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 511 INDONESIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 512 INDONESIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 513 INDONESIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 514 INDONESIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 515 PHILIPPINES HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 516 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 517 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 518 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 519 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 520 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 521 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 522 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 523 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 524 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 525 PHILIPPINES HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 526 PHILIPPINES MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 527 PHILIPPINES OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 528 PHILIPPINES HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 529 PHILIPPINES HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 530 NEW ZEALAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 531 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 532 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 533 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 534 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 535 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 536 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 537 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 538 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 539 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 540 NEW ZEALAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 541 NEW ZEALAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 542 NEW ZEALAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 543 NEW ZEALAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 544 NEW ZEALAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 545 VIETNAM HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 546 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 547 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 548 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 549 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 550 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 551 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 552 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 553 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 554 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 555 VIETNAM HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 556 VIETNAM MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 557 VIETNAM OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 558 VIETNAM HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 559 VIETNAM HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 560 REST OF ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 561 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 562 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 563 MIDDLE EAST AND AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 564 MIDDLE EAST AND AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 565 MIDDLE EAST AND AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 566 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 567 MIDDLE EAST AND AFRICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 568 MIDDLE EAST AND AFRICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 569 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 570 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 571 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 572 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 573 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 574 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 575 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 576 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 577 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 578 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 579 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 580 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 581 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 582 SOUTH AFRICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 583 SOUTH AFRICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 584 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 585 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 586 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 587 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 588 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 589 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 590 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 591 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 592 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 593 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 594 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 595 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 596 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 597 SAUDI ARABIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 598 SAUDI ARABIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 599 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 600 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 601 U.A.E. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 602 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 603 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 604 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 605 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 606 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 607 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 608 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 609 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 610 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 611 U.A.E. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 612 U.A.E. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 613 U.A.E. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 614 U.A.E. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 615 U.A.E. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 616 EGYPT HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 617 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 618 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 619 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 620 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 621 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 622 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 623 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 624 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 625 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 626 EGYPT HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 627 EGYPT MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 628 EGYPT OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 629 EGYPT HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 630 EGYPT HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 631 ISRAEL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 632 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 633 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 634 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 635 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 636 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 637 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 638 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 639 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 640 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 641 ISRAEL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 642 ISRAEL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 643 ISRAEL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 644 ISRAEL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 645 ISRAEL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 646 KUWAIT HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 647 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 648 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 649 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 650 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 651 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 652 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 653 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 654 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 655 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 656 KUWAIT HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 657 KUWAIT MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 658 KUWAIT OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 659 KUWAIT HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 660 KUWAIT HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 661 QATAR HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 662 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 663 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 664 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 665 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 666 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 667 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 668 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 669 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 670 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 671 QATAR HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 672 QATAR MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 673 QATAR OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 674 QATAR HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 675 QATAR HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 676 OMAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 677 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 678 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 679 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 680 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 681 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 682 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 683 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 684 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 685 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 686 OMAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 687 OMAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 688 OMAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 689 OMAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 690 OMAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 691 BAHRAIN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 692 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 693 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 694 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 695 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 696 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 697 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 698 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 699 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 700 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 701 BAHRAIN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 702 BAHRAIN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 703 BAHRAIN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 704 BAHRAIN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 705 BAHRAIN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 706 REST OF MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

Список рисунков

FIGURE 1 GLOBAL HEART VALVE DEVICES MARKET: SEGMENTATION

FIGURE 2 GLOBAL HEART VALVE DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL HEART VALVE DEVICES MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL HEART VALVE DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL HEART VALVE DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL HEART VALVE DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL HEART VALVE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 GLOBAL HEART VALVE DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL HEART VALVE DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL HEART VALVE DEVICES MARKET: SEGMENTATION

FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL HEART VALVE DEVICES MARKET, AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD

FIGURE 12 GROWING PREVALENCE OF VALVULAR DISEASES, SUCH AS AORTIC STENOSIS & AORTIC REGURGITATION, AND INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES ARE EXPECTED TO DRIVE THE GLOBAL HEART VALVE DEVICES MARKET IN THE FORECAST PERIOD

FIGURE 13 MECHANICAL HEART VALVE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL HEART VALVE DEVICES MARKET IN 2023 & 2030

FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR HEART VALVE DEVICES MANUFACTURERS IN THE FORECAST PERIOD

FIGURE 15 INCIDENDE AND PREVALENCE OF HEART VALVE OF NORTH AMERICA

FIGURE 16 INCIDENDE AND PREVALENCE OF HEART VALVE OF EUROPE

FIGURE 17 INCIDENDE AND PREVALENCE OF HEART VALVE OF ASIA-PACIFIC

FIGURE 18 INCIDENDE AND PREVALENCE OF HEART VALVE OF SOUTH AMERICA & MIDDLE EAST AND AFRICA

FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL HEART VALVE DEVICES MARKET

FIGURE 20 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2022

FIGURE 21 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)

FIGURE 22 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, CAGR (2023-2030)

FIGURE 23 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 24 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, 2022

FIGURE 25 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, 2023-2030 (USD MILLION)

FIGURE 26 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, CAGR (2023-2030)

FIGURE 27 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, LIFELINE CURVE

FIGURE 28 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, 2022

FIGURE 29 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, 2023-2030 (USD MILLION)

FIGURE 30 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, CAGR (2023-2030)

FIGURE 31 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, LIFELINE CURVE

FIGURE 32 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2022

FIGURE 33 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 34 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 35 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 36 GLOBAL HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 37 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2022)

FIGURE 38 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2023 & 2030)

FIGURE 39 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2022 & 2030)

FIGURE 40 GLOBAL HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)

FIGURE 41 NORTH AMERICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 42 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)

FIGURE 43 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)

FIGURE 44 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)

FIGURE 45 NORTH AMERICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)

FIGURE 46 SOUTH AMERICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 47 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)

FIGURE 48 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)

FIGURE 49 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)

FIGURE 50 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)

FIGURE 51 EUROPE HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 52 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2022)

FIGURE 53 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)

FIGURE 54 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)

FIGURE 55 EUROPE HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)

FIGURE 56 ASIA-PACIFIC HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 57 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2022)

FIGURE 58 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)

FIGURE 59 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)

FIGURE 60 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY FUNCTIONALITY (2023-2030)

FIGURE 61 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 62 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)

FIGURE 63 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)

FIGURE 64 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)

FIGURE 65 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)

FIGURE 66 GLOBAL HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)

FIGURE 67 NORTH AMERICA HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)

FIGURE 68 EUROPE HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)

FIGURE 69 ASIA-PACIFIC HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)

View Detailed Information Right Arrow

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Просмотр связанных страниц

Banner
Testimonial
Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future

Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future

Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.